Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kerr

Showing results (31-40 of 315) with videos related to

Pageof 32
Sort By:
Journal of Diabetes Science and Technology|September 2, 2011
Using insulin in type 2 diabetes: in need of a renaissance?David Kerr, Tolulope Olateju
The Lancet. Diabetes & Endocrinology|April 4, 2022
Breakthrough technology for in-hospital glucose monitoringDavid Kerr, David Klonoff
Current Opinion in Oncology|June 10, 2004
Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003Ray Chan, David Kerr
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Bevacizumab--current status and future directionsRachel Midgley, David Kerr
Nature Reviews. Cancer|July 25, 2006
A new model for cancer research in FranceDavid Khayat, David Kerr
Expert Review of Anticancer Therapy|April 13, 2007
Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and futureAmi Sabharwal, David Kerr
Journal of Diabetes Science and Technology|October 14, 2020
Clouds and Silver Linings: COVID-19 Pandemic Is an Opportune Moment to Democratize Diabetes Care Through TelehealthDavid Kerr, Hope Warshaw
The Lancet. Diabetes & Endocrinology|October 4, 2020
Diabetes, like COVID-19, is a wicked problemDavid Kerr, Namino Glantz
Lancet (London, England)|October 29, 2002
Nutrition, physical activity, and obesityDavid Kerr, Janet James
American Journal of Clinical Dermatology|September 26, 2003
Skin-related complications of insulin therapy: epidemiology and emerging management strategiesTristan Richardson, David Kerr
Pageof 32

Showing results (31-40 of 315) with videos related to

Sort By:
Pageof 32
Journal of Diabetes Science and Technology|September 2, 2011
Using insulin in type 2 diabetes: in need of a renaissance?David Kerr, Tolulope Olateju
The Lancet. Diabetes & Endocrinology|April 4, 2022
Breakthrough technology for in-hospital glucose monitoringDavid Kerr, David Klonoff
Current Opinion in Oncology|June 10, 2004
Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003Ray Chan, David Kerr
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Bevacizumab--current status and future directionsRachel Midgley, David Kerr
Nature Reviews. Cancer|July 25, 2006
A new model for cancer research in FranceDavid Khayat, David Kerr
Expert Review of Anticancer Therapy|April 13, 2007
Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and futureAmi Sabharwal, David Kerr
Journal of Diabetes Science and Technology|October 14, 2020
Clouds and Silver Linings: COVID-19 Pandemic Is an Opportune Moment to Democratize Diabetes Care Through TelehealthDavid Kerr, Hope Warshaw
The Lancet. Diabetes & Endocrinology|October 4, 2020
Diabetes, like COVID-19, is a wicked problemDavid Kerr, Namino Glantz
Lancet (London, England)|October 29, 2002
Nutrition, physical activity, and obesityDavid Kerr, Janet James
American Journal of Clinical Dermatology|September 26, 2003
Skin-related complications of insulin therapy: epidemiology and emerging management strategiesTristan Richardson, David Kerr
Pageof 32